Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Trial to Assess Mobilization of Hematopoietic Progenitor Cells With a Combination of Bortezomib and G-CSF in Patients Undergoing Autologous Transplant for Myeloma and Lymphoma

NCT01171092 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.

NCT NCT01171092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01171092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Trial to Assess Mobilization of Hematopoietic Progenitor Cells With a Combination of Bortezomib and G-CSF in Patients Undergoing Autologous Transplant for Myeloma and Lymphoma
Lead sponsor
University of Kansas Medical Center
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2010
Completion date
December 31, 2014
Enrollment
21 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

autologous transplant, malignant lymphoma, stem cell type